AXS (company)

News and Video Search Results

News coverage

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting

GlobeNewswire 15 Apr 2024

AXS-05 in Alzheimer’s disease agitation data featured in oral plenary sessionNew data for AXS-07 in migraine demonstrating..

AXSOME ALERT: Bragar Eagel & Squire, P.C. is Investigating Axsome Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire 12 Apr 2024
AXIS Capital to Release First Quarter Financial Results on May 1, 2024
Business Wire 10 Apr 2024
Excessive Daytime Sleepiness Market is Projected to Boost at a Moderate Growth Rate by 2032, Predicts DelveInsight | Key Companies in the Market - Avadel Pharmaceutical, Axsome Therapeutic, Theranexus, XWPharma, Takeda Pharmaceutical
GlobeNewswire 09 Apr 2024
AXIS Capital Announces Publication of the Company's 2023 Loss Development Triangles
Business Wire 25 Mar 2024

0 shares 1 views

You might like

AXS (company) media coverage

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

GlobeNewswire 25 Mar 2024

77% of narcolepsy type 1 patients continue to experience cataplexy attacks despite being treated

64% of narcolepsy type..

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
GlobeNewswire 25 Mar 2024
AXIS Promotes Kyle Freeman to Head of ILS
Business Wire 21 Mar 2024
Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
GlobeNewswire 19 Mar 2024
AXIS Appoints W. Marston Becker as Chair-Elect of Board of Directors
Business Wire 29 Feb 2024

Advertisement

More coverage

AXIS Names Stephen Lord as Global Chief Information Officer; Robert Barriero as Global Head of Strategic Sourcing and Corporate Real Estate

Business Wire 28 Feb 2024

PEMBROKE, Bermuda--(BUSINESS WIRE)---- $AXS #insurance--AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”)..

Japan Construction Equipment Market Asessment & Forecast 2024-2029: Market to Grow to 156,791 Units by 2029, Growing at a CAGR of 4.24%
GlobeNewswire 15 Feb 2024
Medical Animation Market Size & Share to Exceed USD 3.4 Billion by 2034, at CAGR of 21.0% – PMI
GlobeNewswire 07 Feb 2024
Binance Co-Founder Says up to $5,000,000 Rewards Available for Information on Pre-Listing Insider Trading
Upworthy 07 Feb 2024
Chronic Pain Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Players - Paradigm Biopharmaceuticals, Noven Pharmaceuticals, Pfizer, Biogen, Tonix Pharmaceuticals, Amzell, Bayer, and Others
GlobeNewswire 07 Feb 2024